Assembly Biosciences Inc. (ASMB) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Assembly Biosciences Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$20.57
+1.33% today
Market cap
$413M
Overall quality
60/100
Kronos AI 30-day
+28.7%
8 of 8 simulated paths end higher
Assembly Biosciences Inc. (ASMB) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $413M. It trades at $20.57, up 1.33% today. Its overall quality score is 60 out of 100, ranked against the whole US market. 4 analysts' average target of $49.50 implies +140.6% from today's price. Kronos AI's 30-day forecast is +28.7% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $49.50 |
| Low – high | $43.00 – $53.00 |
| Analysts | 4 |
| Upside to average | +140.6% |
Kronos AI 30-day forecast
| Expected close | $26.13 (+28.7%) |
| Likely range | +22.0% … +34.5% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 31 |
| Solvency | 61 |
| Growth | 87 |
| Overall | 60 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.